Executive Collapses During Oval Office Press Conference
Gordon Findlay, an executive from Novo Nordisk, unexpectedly collapsed while standing behind President Donald Trump at a press event inside the White House. The announcement was about a new agreement related to weight-loss medications.
Suddenly, Findlay’s knees gave way, causing concern among officials and pharmaceutical representatives who immediately moved to prevent him from falling to the floor.
Response from White House Officials
“During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted. The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.”
— White House Press Secretary Karoline Leavitt
Karoline Leavitt confirmed on site medics attended to Findlay, and he was reported to be fine. The press conference briefly paused but was expected to continue soon after.
Assistance Provided
Witnesses said Dr. Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services, helped Findlay safely to the ground to avoid head injuries. Reporters were then asked to leave the Oval Office while cabinet members attended to him and elevated his legs.
Key Details
- Event: Announcement of new weight-loss medication deal
- Location: Oval Office, White House
- Involved: Gordon Findlay (Novo Nordisk executive), President Donald Trump, Dr. Mehmet Oz
- Immediate medical aid provided by White House Medical Unit
- Press conference briefly paused but resumed shortly after
Summary: During a press conference at the White House announcing a weight-loss drug deal, Novo Nordisk executive Gordon Findlay fainted but quickly received medical attention, ensuring his safety and a swift return to the event.